See Today's Golden Star Stocks 🔥 Free for 7 Days See Today's Golden Star Stocks 🔥 Free for 7 Days

News Digest / Income Statements

Income Statements

09:01am, Wednesday, May 14, 2025

IO Biotech Reports Increased Losses in Q1 2025 Amid Advancements in Cancer Vaccine Development

Company Overview: IO Biotech, Inc. (NASDAQ: IOBT) is a clinical-stage biopharmaceutical company focused on developing novel immune-modulatory therapeutic cancer vaccines utilizing its T-win® platform. Recent Income Statement Highlights for Q1 2025: Net Loss: $22.4 million, compared to $19.5 mill...

09:00am, Wednesday, May 14, 2025

Sow Good Inc. Faces Financial Struggles with Significant Revenue Decline and Rising Net Losses

08:06am, Wednesday, May 14, 2025

Milestone Pharmaceuticals Reports Q1 2025 Financial Losses Amid Etripamil Development Challenges

08:06am, Wednesday, May 14, 2025

HG Holdings Reports Q1 2025 Results: Rising Revenues Offset by Increased Net Loss and Expenses

S

08:05am, Wednesday, May 14, 2025

ARS Pharmaceuticals Reports Strong Revenue Growth but Faces Significant Operating Losses and Challenges

08:05am, Wednesday, May 14, 2025

Unicycive Therapeutics Reports Q1 2025 Turnaround with $570K Net Income Amid Ongoing Financial Challenges

08:04am, Wednesday, May 14, 2025

Foghorn Therapeutics Reports Improved Finances Amid Ongoing Losses and Strategic Partnerships

08:04am, Wednesday, May 14, 2025

Lexicon Pharmaceuticals Reports Mixed Q1 2025 Results Amid Revenue Growth and High Deficit Concerns

08:04am, Wednesday, May 14, 2025

Charlotte's Web Holdings Reports Q1 2025 Financials: Revenue Up, Losses Narrowing Amid Challenges

08:03am, Wednesday, May 14, 2025

Benitec Biopharma Reports Q3 Losses Rise Amid Increased R&D Spending and Strong Cash Reserves

08:03am, Wednesday, May 14, 2025

Climb Bio Reports Q1 2025 Losses Amidst R&D Growth and Regulatory Challenges

08:03am, Wednesday, May 14, 2025

Centessa Pharmaceuticals Reports First Revenue Amid Growing Risks and Clinical Developments

08:02am, Wednesday, May 14, 2025

Scholar Rock Advances with Positive Trial Results as Financial Losses Surge in Q1 2025

08:02am, Wednesday, May 14, 2025

Verve Therapeutics Sees Revenue Surge Amid Challenges in Gene Therapy for Cardiovascular Disease

08:01am, Wednesday, May 14, 2025

Advanced Flower Capital Reports Strong Q1 2025 Recovery Despite Declining Interest Income

08:01am, Wednesday, May 14, 2025

Marathon Bancorp Reports Strong Q3 2025 Recovery with Increased Net Income and Loan Growth

M

08:00am, Wednesday, May 14, 2025

Inozyme Pharma Reports Q1 2025 Results: Progress Amid Rising Losses and Financial Challenges

07:03am, Wednesday, May 14, 2025

Yubo International Biotech Reports Zero Revenue and Rising Losses in Challenging Q1 2025

Y

07:02am, Wednesday, May 14, 2025

Firefly Neuroscience Faces Revenue Growth Amid Rising Losses and Operating Expenses

07:02am, Wednesday, May 14, 2025

New Momentum Corp Reports Q1 2025 Earnings: Revenue Plummets, Financial Stability in Question

N

07:02am, Wednesday, May 14, 2025

LadRx Corporation Reports Significant Net Loss and Dwindling Cash Reserves in Q1 2025 Financials

07:01am, Wednesday, May 14, 2025

China Automotive Systems Reports Mixed Q1 2025 Results Amid Growing Sales and Rising Costs

C

07:01am, Wednesday, May 14, 2025

Nexien BioPharma Reports Improved Losses Amid Ongoing Financial Struggles and No Revenue Generation

07:01am, Wednesday, May 14, 2025

DarioHealth Reports Revenue Growth Amid Widening Net Loss and Strategic Partnerships

D

07:00am, Wednesday, May 14, 2025

Greenpro Capital Corp Reports Significant Revenue Decline and Rising Losses in Q1 2025

06:12pm, Tuesday, May 13, 2025

Xenetic Biosciences Reports Revenue Growth Amid Ongoing Financial Challenges in Q1 2025

06:12pm, Tuesday, May 13, 2025

NexGel Reports Strong Revenue Growth Despite Ongoing Profitability and Liquidity Challenges

N

06:12pm, Tuesday, May 13, 2025

Mountain Lake Acquisition Corp. Reports Q1 2025 Financial Highlights Amidst Acquisition Challenges

M

06:11pm, Tuesday, May 13, 2025

Nuwellis Reports Mixed Q1 2025 Results: Improved Losses but Declining Cash Reserves

06:11pm, Tuesday, May 13, 2025

Netlist Reports Q1 2025 Results: Improved Losses Amid Declining Sales and Cash Flow Challenges

06:10pm, Tuesday, May 13, 2025

Avalon GloboCare Reports Increased Q1 Loss Amid Rising Costs and Mixed Financial Performance

06:10pm, Tuesday, May 13, 2025

Hycroft Mining Reports Q1 Loss Improvement Amid Continued Operational Challenges and Liquidity Concerns

06:10pm, Tuesday, May 13, 2025

Lightwave Logic Reports Q1 2025 Results: Lower Losses Amid Ongoing Revenue Challenges

06:09pm, Tuesday, May 13, 2025

ACCESS Newswire Reports Mixed Q1 Earnings Amid Revenue Decline and Strategic Divestiture Success

06:09pm, Tuesday, May 13, 2025

High Wire Networks Reports Mixed Quarterly Results Amid Financial Challenges and Strategic Shifts

06:08pm, Tuesday, May 13, 2025

Landstar Reports Q1 2025 Decline in Net Income and Revenue Amid Market Challenges

06:08pm, Tuesday, May 13, 2025

M-tron Industries Reports Strong Q1 2025 Growth Amid Rising Costs and Margin Pressures

M

06:08pm, Tuesday, May 13, 2025

DISH Network Reports Declining Revenues, Rising Losses, and Mixed Subscriber Trends in Q1 2025

06:07pm, Tuesday, May 13, 2025

Humacyte Reports Strong Q1 2025 Earnings with $39.1M Net Income, Yet Faces Ongoing Financial Risks

06:07pm, Tuesday, May 13, 2025

NeuroPace Reports Revenue Growth Amid Persistent Losses and Strategic Operational Changes

«
1
2
...
67
68
69
70
71
72
73
...
111
112
»